ID   FM55p.R22.2
AC   CVCL_C592
SY   FM-55-p.R22.2; FM55P.R22
DR   ECACC; 13012462
DR   ESTDAB; ESTDAB-015
DR   Wikidata; Q54835049
RX   PubMed=8665567;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012462; ESTDAB=ESTDAB-015
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   FGA: 24
ST   TH01: 5,7
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C591 ! FM55p
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 13
//
RX   PubMed=8665567; DOI=10.1007/s002620050272; PMCID=PMC11037612;
RA   Kirkin, Alexei F.
RA   thor Straten, Per
RA   Zeuthen, Jesper
RT   "Differential modulation by interferon gamma of the sensitivity of
RT   human melanoma cells to cytolytic T cell clones that recognize
RT   differentiation or progression antigens.";
RL   Cancer Immunol. Immunother. 42:203-212(1996).
//